Skip to main content
Article thumbnail
Location of Repository

Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

By Cosette M. Wheeler, William C. Hunt, Nancy E. Joste, Charles R. Key, Wim G. V. Quint and Philip E. Castle
Topics: Articles
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:2664090
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). A comparison of linear array and line blot assay for detection of HPV and cervical precancer and cancer in the ASCUS LSIL triage study . J Clin Microbiol.
    2. (2008). A comparison of two PCR-based human papillomavirus genotyping methods [published online ahead of print
    3. A prospective study of age trends in cervical human papillomavirus acquisition and persistence
    4. (2002). A prospective study of highgrade cervical neoplasia risk among human papillomavirus-infected women .
    5. (2008). A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States . Cancer Epidemiol Biomarkers Prev .
    6. (2006). American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. [published erratum appears
    7. (2005). Cervical cancer in women with comprehensive health care access: attributable factors in the screening process .
    8. (2008). Cervical cancer screening following prophylactic human papillomavirus vaccination [review] . Vaccine .
    9. (1999). Cervical cancer screening: which techniques should be used and why? Clin Obstet Gynecol .
    10. (2009). de la Rochefordière A , Savignoni A , et al . Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype .
    11. (2001). Determinants of genital human papillomavirus detection in a US population . J Infect Dis .
    12. (1999). Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identifi cation of anogenital human papillomavirus . J Clin Microbiol.
    13. (2003). Epidemiologic classifi cation of human papillomavirus types associated with cervical cancer .
    14. (2002). Genotyping of human papillomavirus by the PGMY-line blot and the SPF10-line probe assay in liquid cytology cervical specimens . J Clin Microbiol.
    15. (2007). Health Protection Agency . Health Protection Report . 2007;1(35) . Health Protection Agency ;
    16. (2001). Human papillomavirus and prognosis of invasive cervical cancer: a population-based study . J Clin Oncol .
    17. (1992). Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types . Obstet Gynecol .
    18. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide . J Pathol .
    19. (1996). Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer .
    20. (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a metaanalysis update .
    21. (2000). Improved amplifi cation of genital human papillomaviruses .
    22. Incidence trends of adenocarcinoma of the cervix in
    23. (2007). Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing [review] . Cancer .
    24. (1958). Mortality from lung cancer and chronic obstructive pulmonary disease in
    25. (1999). Natural history of dysplasia of the uterine cervix .
    26. (1998). Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses .
    27. (2003). Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix . Cancer .
    28. (2006). Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis . Lancet .
    29. (1999). Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas . Cancer Epidemiol Biomarkers Prev .
    30. (2007). Prevalence of HPV infection among females in the United States . JAMA .
    31. (2008). Prevalence of type-specifi c HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial .
    32. (2005). Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse .
    33. (2004). Projected clinical benefi ts and costeffectiveness of a human papillomavirus 16/18 vaccine .
    34. (2006). Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality . Cancer Res.
    35. (1999). Risk factors for rapidonset cervical cancer .
    36. (1994). Sample preparation and PCR amplifi cation from paraffi n-embedded tissues . PCR Methods Appl.
    37. (2004). SEER*Stat Database: Incidence — SEER 9 Regs Public-Use,
    38. (2003). Smoking and cervical cancer: pooled analysis of the IARC multi-centric case – control study . Cancer Causes Control .
    39. (2006). Sustained effi cacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial . Lancet .
    40. (2005). The carcinogenicity of human papillomavirus types refl ects viral evolution . Virology .
    41. (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specifi c HPV testing in clinical practice . J Natl Cancer Inst .
    42. (2007). The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report . Am J Clin Pathol .
    43. (2000). The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States — a 24-year population-based study . Gynecol Oncol .
    44. (2008). Type-dependent integration frequency of human papillomavirus genomes in cervical lesions . Cancer Res.
    45. (2000). Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix . Gynecol Oncol .
    46. (2007). Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type .
    47. (2004). zur Hausen HH . Classifi cation of papillomaviruses . Virology .

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.